Intravenous and Inhaled Epoprostenol for Primary Pulmonary Hypertension During Pregnancy and Delivery
Authors:
- I BildiriciIBI Bildirici
- J B. ShumwayJSJ B. Shumway
- 1 May 2004
- journal article
- case report
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 103 (5) , 1102-1105
Abstract
Primary pulmonary hypertension carries a significant mortality risk during pregnancy and delivery. A 36-year-old pregnant woman with primary pulmonary hypertension was transferred to us with severe dyspnea. Intravenous epoprostenol was started, titrated, and maintained until labor augmentation. Because systemic epoprostenol treatment can interfere with platelet aggregation, we switched to inhaled epoprostenol, administered under a U.S. Food and Drug Administration-approved investigational new drug license, before epidural catheter placement. The inhaled drug was continued because it achieved better control of pulmonary hypertension. An uneventful forceps-assisted vaginal delivery was performed, and intravenous epoprostenol was restarted after the delivery. Mother and baby were well 6 months postpartum. Intravenous epoprostenol treatment is effective in management of pregnant and postpartum women with primary pulmonary hypertension. Inhaled epoprostenol was effective during the intrapartum and immediate postpartum period.Keywords
This publication has 11 references indexed in Scilit:
- Pregnancy and Primary Pulmonary HypertensionChest, 2001
- Pregnant Patient with Primary Pulmonary Hypertension: Inhaled Pulmonary Vasodilators and Epidural Anesthesia for Cesarean DeliveryAnesthesiology, 2000
- Pulmonary hypertension in pregnancy: treatment with pulmonary vasodilatorsObstetrics & Gynecology, 1999
- Anaesthesia for caesarean section in the presence of severe primary pulmonary hypertensionBritish Journal of Anaesthesia, 1998
- Outcome of Pulmonary Vascular Disease in Pregnancy: A Systematic Overview From 1978 Through 1996JACC, 1998
- An evaluation of nebulized prostacyclin in patients with primary and secondary pulmonary hypertensionEuropean Heart Journal, 1997
- A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary HypertensionNew England Journal of Medicine, 1996
- Pulmonary hypertension and pregnancy: a series of eight casesCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1994
- The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary HypertensionNew England Journal of Medicine, 1992
- Treatment of Primary Pulmonary Hypertension with Continuous Intravenous Prostacyclin (Epoprostenol)Annals of Internal Medicine, 1990